PRGO Perrigo Corp: מקדם חוב לטווח ארוך להון

Perrigo Company plc (PRGO) dominates the OTC segment, leveraging a pipeline of affordable generics and an extensive retail network to drive margin growth. This price chart confirms its status as a reliable B2B partner producing medications for the largest pharmacy brands. The indicator stands at 1.47, underscoring the resilience of a closed private label ecosystem protected from external players by stringent FDA requirements.

This indicator measures the proportion of long-term liabilities within the equity structure, determining the degree of financial leverage and the company's resilience to long-term credit risks. For Perrigo Company plc (PRGO), the regionalization of raw material supply chains requires capital expenditures; therefore, analyzing the ratio of long-term loans to equity allows for an assessment of how effectively the company finances its logistical transformation without risking default.